Drug intelligence / Profile preview

human insulin isophane

Development stage
Unknown
Lead developer
BIOTON
Modality
Recombinant Proteins and Enzymes, Peptides
Administration
Subcutaneous
01

Overview

Gensulin N is an intermediate-acting recombinant human insulin (NPH/isophane) developed by BIOTON for the management of diabetes mellitus. It is produced using recombinant DNA technology and formulated as a crystalline suspension with protamine and zinc, which delays its absorption from the subcutaneous injection site, resulting in a prolonged duration of action compared to regular soluble insulin. The drug acts as an agonist at the insulin receptor, stimulating glucose uptake in peripheral tissues such as skeletal muscle and adipose tissue, while simultaneously inhibiting hepatic glucose production. It is typically used to provide basal insulin coverage throughout the day or night.

Brand names
Gensulin N
Other names
NPH insulinIsophane insulinNeutral Protamine Hagedorn insulinHuman insulin isophane
02

Targets

INSR (Insulin receptor)

Beyond the preview

Go deeper on human insulin isophane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on human insulin isophane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call